biomedicina slovenica


"INTERFERON-BETA" : 25

  1. Stopinšek Sanja; Simčič Saša; Plankl Mojca; Rot Uroš; Ihan Alojz
    Uporaba rezultatov o nevtralizirajočih protitelesih proti interferonu-beta pri bolnikih z multiplo sklerozo
    2013
  2. Fajs Luka; Resman Rus Katarina; Avšič-Županc Tatjana
    Crimean-Congo hemorrhagic fever virus nucleoprotein suppresses IFN-beta-promoter-mediated gene expression
    2013
  3. Hartung HP; Freedman MS; Polman CH; Šega-Jazbec Saša
    Interferon beta-1b-neutralizing antibodies 5 years after clinically isolated syndrome
    2011
  4. O'Connor Paul; Filippi Massimo; Arnason Barry; Šega-Jazbec Saša
    250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
    2009
  5. Kappos Ludwig; Freedman Mark S; Polman Chris H; Šega Jazbec Saša
    Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial
    2009
  6. Rot U; Sominanda A; Fogdell-Hahn A; Hillert J
    Impression of clinical worsening fails to predict interferon-beta neutralizing antibody status
    2008
  7. Šega Saša; Horvat Alenka; Rot Uroš; Wraber Branka; Ihan Alojz
    Could cytokines levels or adhesion molecules expression be predictor of IFN-beta treatment response in multiple sclerosis patients?
    2008
  8. Sominanda A; Rot U; Suoniemi M; Deisenhammer F; Hillert J; Fogdell-Hahn A
    Interferon beta preparations for the treatment of multiple sclerosis patients differ in neutralizing antibody seroprevalence and immunogenicity
    2007
  9. Šega Saša; Horvat Alenka; Popović Mara
    Anaplastic oligodendroglioma and gliomatosis type 2 in interferon-beta treated multiple sclerosis patients: report of two cases
    2006
  10. Šega-Jazbec Saša
    Primerjava vpliva terapije z interferonom beta-1a in interferonom beta-1b na potek bolezni, citokine in adhezijske molekule pri bolnikih z recidivno-remitentno multiplo sklerozo
    2005
  11. van Holten J; Pavelka K; Vencovsky J; Stahl H; Rozman B; Genovese M; Kivitz AJ; ALvaro J; Nuki G; Furst DE
    A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1-a in the treatment of patients with active rheumatoid arthritis
    2005
  12. Liščić Rajka M; Brecelj Jelka
    Visual evoked potentials in multiple sclerosis patients treated with interferon beta-1a
    2004
  13. Perišić S; Perišić Z; Tasić L; Vasiljević M
    Treatment of condylomata acuminata - surgical excision and CO2 laser vaporization
    2004
  14. Horvat-Ledinek Alenka
    Primerjava uspešnosti zdravljenja bolnikov z multiplo sklerozo z interferonom beta-1b in glatiramer acetatom
    2001
  15. Horvat Alenka
    Zdravljenje multiple skleroze
    2000
  16. Fleischmann W Robert Jr; Koren Srečko
    Systemic effects of orally administered interferons and interleukin-2
    1999
  17. Končan-Vračko Beatrika
    Napredek znanosti v zdravljenju oseb z multiplo sklerozo: novosti v letu 1998
    1998
  18. Meh Duška; Denišlič Miro
    Interferon beta-1B
    1996
  19. Denišlič M; Šega-Jazbec S
    Zdravljenje multiple skleroze
    1996
  20. Štalc A
    Pregled v zdravljenje uvedenih rekombinantnih zdravil
    [A review of recombinant drugs introduced into the therapy]
    1996
  21. Denišlič M
    Betaferon pri zdravljenju bolnikov z multiplo sklerozo
    1996
  22. Baumhackl U
    Management of multiple sclerosis patients with interferon beta-therapy - experience from Austria
    1995
  23. Koren S; Fleischmann WR Jr
    Orally administered interferons suppress bone marrow function (43646)
    1993
  24. Cencič A; Filipič B
    Biological activity of rat fibroblast interferon beta
    1993
  25. Kotnik V; Fleischmann WR Jr
    IFN alpha/beta, IFN gamma, TNF alpha and combinations of IFN gamma/TNF alpha as C57B1/6 mice bone marrow cells proliferation inhibitors and differentiation factors
    1990



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics